Close search filters
Changing filters will change the listed Success Criteria and Techniques
Category
Topic
Search results (166)
Article
PBMs and the drug pipeline: Anticipating tomorrow while affording today
October 04, 2024
Article
What to look for in the upcoming gene therapy pipeline
April 20, 2023
As the gene therapy landscape continues to evolve, plan sponsors should familiarize themselves with the tools and strategies necessary to navigate the future of these game-changing treatments.
Article
Addressing health disparities in cancer care
March 04, 2025
Employers can take the lead in addressing health disparities and implementing strategies to serve vulnerable populations.
Article
Leveraging biosimilars to drive savings and support patient access
July 01, 2024
By the end of 2024, 3 FDA-approved biosimilars to Stelara for patients living with inflammatory conditions will be closer to launch, enabling lower total drug spend.
Article
Boosting Biosimilars Competition and Savings
September 25, 2023
An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...
Article
Outcomes 2024: How Evernorth manages the drug pipeline today and prepares for tomorrow
May 08, 2024
Newsroom
Express Scripts Introduces New Option to Give Clients Maximum Simplicity in Drug Pricing
November 14, 2023
Express Scripts ClearNetwork offers employers and health plans a new option for simple, “cost-plus” pharmacy pricing for brand, generic, and specialty medications.
Article
Employer expectations for cancer care in 2025
January 14, 2025
Rise in cancer incidence, technological advancements and health care costs will have a significant impact on health outcomes and employers’ bottom line.
Article
A journey through infertility: Jillian's story
March 12, 2025
By sharing her experience, Jillian hopes to encourage others to seek help and feel comfortable discussing their struggles.